Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
AK112, Cadonilimab, nab-paclitaxel, gemcitabine
Akeso
Metastatic Pancreatic Ductal Adenocarcinoma
1 trial -
Cadonilimab
Second Affiliated Hospital of Soochow University
Immunotherapy
1 trial -
Cadonilimab
The First People's Hospital of Lianyungang
Immunotherapy
1 trial -
Cadonilimab
The First People's Hospital of Lianyungang
Lung Cancer
1 trial -
Cadonilimab
The First People's Hospital of Lianyungang
Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
1 trial -
Cadonilimab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cervical Cancer
1 trial -
Nab-paclitaxel Combined With Cadonilimab (AK104)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Cancer
1 trial -
Paclitaxel Polymeric Micelles for Injection and Cisplatin combined with Cadonilimab
The First People's Hospital of Lianyungang
Locally Advanced Esophageal Squamous Cell Carcinoma
1 trial -
cadonilimab combined +paclitaxel (albumin-bound)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Adenocarcinoma
1 trial -
Cadonilimab
The First People's Hospital of Lianyungang
Locally Advanced Esophageal Squamous Cell Carcinoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources